Search

Mary F Klotman

from Durham, NC
Age ~71
Get Report
Also known as:
Mary E Klotman, Mary Dr Klotman, Mary Easley Klotman, Mary S Klotman, Paul E Klotman, Paul Evan Klotman, Paul N
Phone and address:
3960 Plymouth Rd, Durham, NC 27707
(919) 294-9684
Related to:
Sarah M Banchefsky, 38R KlotmanPhyllis R KlotmanPaul E Klotman, 74Alexander I Klotman, 34Samuel E Klotman
Connected to:
Stacy C Klotovich, 39Krista N Klotter, 57Alexander KlotzAlexandra Klotz, 41Austin N Klotz, 40Charlie Klotz, 83Courtney A Klotz, 49Curt C Klotz, 37Danyel Klotz, 36Darren D Klotz, 58

Mary Klotman Phones & Addresses

  • 3960 Plymouth Rd, Durham, NC 27707 (919) 294-9684
  • 387 End Ave, New York, NY 10024 (212) 769-3916
  • 424 End Ave, New York, NY 10024 (212) 787-5377
  • Houston, TX
  • Chevy Chase, MD
  • Chapel Hill, NC
  • Somerville, MA

Work

Company: MOUNT SINAI DEPARTMENT OF RENAL MEDICINE Address: 5 E 98Th St Suite 11Th, New York, NY 10029 Phones: (212) 659-8086 (212) 987-0389

Education

School / High School: Duke University

Skills

Public Speaking

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Infectious Disease, 1986

Industries

Health, Wellness And Fitness

Specialities

Infectious Disease Medicine

Professional Records

Medicine Doctors

Mary Klotman Photo 1

Dr. Mary E Klotman, Durham NC - MD (Doctor of Medicine)

View page
Specialties:
Infectious Disease Medicine
Address:
40 Duke Medicine Cir, Durham, NC 27710
(919) 684-8111 (Phone), (919) 613-6430 (Fax)

MOUNT SINAI DEPARTMENT OF RENAL MEDICINE
5 E 98Th St Suite 11Th, New York, NY 10029
(212) 659-8086 (Phone), (212) 987-0389 (Fax)

Dumc3703 Ryan Suite 1102, Durham, NC 27710
Certifications:
Infectious Disease, 1986
Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
40 Duke Medicine Cir, Durham, NC 27710

Dumc3703 Ryan Suite 1102, Durham, NC 27710

MOUNT SINAI DEPARTMENT OF RENAL MEDICINE
5 E 98Th St Suite 11Th, New York, NY 10029

Mount Sinai Hospital
One Gustave L Levy Place, New York, NY 10029
Education:
Medical School
Duke University
Medical School
Duke University Hospital
Mary Klotman Photo 2

Mary Earley Klotman, New York NY

View page
Specialties:
Internal Medicine
Infectious Disease
Obstetrics & Gynecology
Gynecology
Surgery
Work:
New York University - Mount Sinai
1 Gustave L Levy Pl, New York, NY 10029
Private Diagnostic Clinic
1000 Trent Dr, Durham, NC 27710
Education:
Duke University(1980)
Mary Klotman Photo 3

Mary Earley Klotman, New York NY

View page
Specialties:
Infectious Disease Specialist
Address:
1 Gustave L Levy Pl, New York, NY 10029
Duke University Medical Ctr, Durham, NC 27710
40 Duke Medicine Cir, Durham, NC 27710
Education:
Duke University, School of Medicine - Doctor of Medicine
Duke University Hospital - Fellowship - Infectious Disease (Internal Medicine)
Duke University Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)

Resumes

Resumes

Mary Klotman Photo 4

Dean

View page
Location:
Durham, NC
Industry:
Health, Wellness And Fitness
Work:
Duke University School of Medicine Mar 2010 - Jul 2017
Chairman, Department of Medicine
Duke University School of Medicine Mar 2010 - Jul 2017
Dean
Mt Sinai School of Medicine Sep 1996 - Mar 2010
Chief, Division of Infectious Diseases
Education:
Duke University School of Medicine
Doctor of Medicine, Doctorates, Medicine Duke University
Bachelors, Bachelor of Science, Zoology, Biology
Skills:
Public Speaking

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mary E. Klotman
Medical Doctor
Duke University
College/University
1102 N Irvine Rd, Durham, NC 27710
PO Box 3703, Durham, NC 27710
(919) 684-5384
Mary Earley Klotman
Mary Klotman MD
Internist
1 Gustave L Levy Pl, New York, NY 10029
(212) 241-6741

Publications

Us Patents

Methods Of Inhibiting Viral Infection

View page
US Patent:
7754687, Jul 13, 2010
Filed:
Feb 23, 2006
Appl. No.:
11/360296
Inventors:
Arevik Mosoian - Jackson Heights NY, US
Mary E. Klotman - New York NY, US
Avelino Teixeira - Montclair NJ, US
Assignee:
Mount Sinai School of Medicine - New York NY
International Classification:
A61K 38/22
US Classification:
514 12, 514 21
Abstract:
The present invention is directed to methods of preventing and/or treating infectious disease. In a particular aspect, the invention is directed to treating viral infections by administering an isolated Prothymosin alpha molecule (SEQ ID NO: 2) to a subject in a therapeutically effective amount that reduces the symptoms associated with the viral infection. In a more particular embodiment, the viral infection is caused by a retrovirus, a lentivirus, or a hepatitis virus. In a particular aspect, the viral infection is caused by human immunodeficiency virus-1.

Treatment And Prevention Of Renal Disease

View page
US Patent:
20090220515, Sep 3, 2009
Filed:
Feb 13, 2007
Appl. No.:
12/279128
Inventors:
Michael J. Ross - Hastings-on-hudson NY, US
Paul E. Klotman - New York NY, US
Mary E. Klotman - New York NY, US
Assignee:
MOUNT SINAI SCHOOL OF MEDICINE - New York NY
International Classification:
A61K 39/395
C12Q 1/68
US Classification:
4241391, 435 6
Abstract:
The present invention is directed to a method of treating or preventing renal disease in a subject. This method involves administering the subject an agent which inhibits FAT10 expression in the subject under conditions effective to prevent or treat renal disease. Also disclosed is a method of screening for agents effective in treating or preventing renal disease.

Inhibitors Of Hiv Infection

View page
US Patent:
6358511, Mar 19, 2002
Filed:
May 3, 1999
Appl. No.:
09/305781
Inventors:
Mary E. Klotman - New York NY
Teixeira Avelino - Montclair NJ
Assignee:
Mount Sinai School of Medicine of the City University of New York - New York NY
International Classification:
A01K 3718
US Classification:
4241851, 530327, 530328
Abstract:
The present invention is directed to novel inhibitory compounds which are capable of reducing, eliminating, or preventing human immunodeficiency virus (HIV) infection. These compounds may be polypeptides or peptides comprising particular sequences that inhibit HIV-1 infection. These compounds may be derived from CD8+ lymphocytes. The invention is also directed to novel CD8+ cell lines which secrete these novel inhibitors. The invention is further directed to compositions comprising an inhibitor of the invention and to methods for the use of such compositions in the prevention and/or treatment of HIV infection.
Control profile
Mary F Klotman from Durham, NC, age ~71 Get Report